(100ng/ml) in the presence of saline control or the autophagic flux-inhibition agent chloroquine (CQ). CXCL12 treatment increased autophagy by upregulating the degree of LC3B-II by 20%. CXCL12 treatment also significantly increased co-localization of LC3B and LAMP-2 in serum starved cells. In the present study, we tested the theory that kynurenine plays an opposite role to CXCL12 by suppressing the autophagy cell survival pathway and by inducing apoptosis. Treatment of nutrient-deprived murine BMSCs with 10 or 100 µM of KYN suppresses autophagy in a dose dependent fashion while increasing cellular apoptosis. Treatment of BMSCs with KYN downregulated autophagic flux in BMSC preventing CQ-induced CL3B/LAMP-2 colocalization. KYN treatment prevented conversion of LC3B-I to LC3B-II in CQ-treated cells by 30 percent. At the same time, KYN treatment induces apoptosis, by increasing TUNEL-positive cells number by more than 50 percent. Additionally, KYN treatment significantly increased the levels of cleaved isoforms of PARP and caspase-3. Over 80% of American adults exceed their daily recommended intake of sugar (<10% kcal). While habitual sugar consumption is associated with an increased risk for diabetes and cardiovascular disease, less is known about the effects of short-term sugar consumption on metabolic health, particularly in the elderly. The purpose of this study was to test whether aged hearts are more susceptible to pathology following a short-term high sucrose (HS) diet. Specific goals were to: A) determine the effects of a 1-week HS diet exposure on the hearts of 5 month-old and 24 month-old mice; and B) test if the mitochondrial targeted peptide SS-31 can protect against HS-diet induced effects. Male CB6F1 mice were placed either on standard chow or HS diet after 1 week of receiving saline (control) or SS-31 through osmotic pumps. Heart function was assessed in vivo through echocardiography before and after treatments. One week of HS induced significant cardiac hypertrophy in the old mice compared to age-matched chow controls. Treatment with SS-31 prevented this HS induced hypertrophy. Young hearts were smaller than in the old, but size was unaffected by diet or SS-31. We observed no effect of HS (with or without SS-31) on respiration or H2O2 production in isolated mitochondria from hearts using high-resolution respirometry. These data indicate that only 1-week exposure to HS diet is enough to exacerbate cardiac hypertrophy in aging mice, but factors other than heart mitochondrial ROS may mediate this effect. Interventions to extend lifespan and improve health with increasing age will have significant impact on a growing aged population. Several pharmaceutical interventions extend lifespan in laboratory rodent models with rapamycin, an inhibitor of mechanistic target of rapamycin (mTOR) being the most well studied. Bridging towards translation, we have an ongoing long-term study testing whether rapamycin treatment can extend lifespan and delay the progression of age-related disease in a short-lived non-human primate species, the common marmoset (Callithrix jacchus). We show that daily oral dosing of slow-releasing, encapsulated rapamycin will result in clinically effective concentrations of rapamycin in the blood and inhibit mTOR signaling. This treatment is well tolerated and does not dramatically promote known side effects of this drug, including altering clinical hematology, immune cell subsets, or promoting metabolic dysfunction including glucose intolerance in comparison to control aging marmosets. Unlike previous reports in rodents, rapamycin does not have clear effects on aging cardiovascular function in marmosets. However, in our oldest cohorts daily rapamycin treatment tends to prevent age-associated changes in body mass and composition and prevent decline in kidney function. Now more than three years after beginning treatment, we are now starting to assess the effects of rapamycin on marmoset longevity. When complete, this study will describe for the first time the potential for pharmaceutical intervention to extend longevity of a primate species with the ultimate goal of significant translational impact to human aging. Achieving optimal health and well-being among African American older adults with chronic conditions requires addressing the needs of their caregivers. This study aimed to elucidate how African American females caring for older adults view health and the factors that influence health. We identified African American women ages 24 to 64 caring for an adult 60 years or older for group concept mapping (GCM), a mixed-methods approach. Participants (N=25) first completed idea generation by providing unlimited short, free-text responses to the focus prompt, "A healthy life for a caregiver includes: ___." The 512 identified factors were reduced to 99 unique ideas. Participants then sorted the 99 ideas into clusters based on conceptual similarity and rated each idea on desirability and familiarity. Ratings were recorded on a 5-point Likert scale, ranging from very undesirable to extremely desirable and not at all familiar to extremely familiar. Data were analyzed and mapped via CS Global Max software. A cluster map with 12 outcome domains best fits the data. Identified clusters included: (1) Spirituality, (2) Maintaining relationships, (3) Good character, (4) Action to cope, (5) Preserving self, (6) Support, (7) Personal empowerment, (8) Resources, (9) Release (10) Striving for peace, (11) Wellness, (12) Selfcare. Seven of the 99 ideas (representing 5 of 12 domains) 108
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